Skip to main content
. 2016 Nov 7;7(49):81670–81679. doi: 10.18632/oncotarget.13164

Figure 2. Kaplan–Meier and ROC curves for the seven-miRNA signature in testing set.

Figure 2

A. The Kaplan–Meier curves for testing set (n = 223) divided by the optimum cutoff point. Patients with high scores had poorer outcome in terms of OS (Median OS: 629.6 days vs. 358.3 day, p=0.027. B. The ROC curve for predicting 60 months survival in the testing set.